Financial Snapshot

Revenue
$2.371M
TTM
Gross Margin
-50.55%
TTM
Net Earnings
-$18.06M
TTM
Current Assets
$31.20M
Q1 2024
Current Liabilities
$5.252M
Q1 2024
Current Ratio
593.96%
Q1 2024
Total Assets
$31.79M
Q1 2024
Total Liabilities
$18.82M
Q1 2024
Book Value
$12.97M
Q1 2024
Cash
$29.55M
Q1 2024
P/E
-1.301
Nov 29, 2024 EST
Free Cash Flow
-$17.37M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $4.498M $5.640M $5.260M $3.700M $500.0K $26.90M $900.0K $900.0K $500.0K $0.00 $6.200M $2.100M $4.700M $27.70M $63.20M $38.50M $41.30M $38.80M $44.80M $33.00M $118.9M $64.50M $28.30M $5.700M $4.100M $2.900M $4.600M $2.000M
YoY Change -20.25% 7.22% 42.16% 640.0% -98.14% 2888.89% 0.0% 80.0% -100.0% 195.24% -55.32% -83.03% -56.17% 64.16% -6.78% 6.44% -13.39% 35.76% -72.25% 84.34% 127.92% 396.49% 39.02% 41.38% -36.96% 130.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $4.498M $5.640M $5.260M $3.700M $500.0K $26.90M $900.0K $900.0K $500.0K $0.00 $6.200M $2.100M $4.700M $27.70M $63.20M $38.50M $41.30M $38.80M $44.80M $33.00M $118.9M $64.50M $28.30M $5.700M $4.100M $2.900M $4.600M $2.000M
Cost Of Revenue $222.0K $157.0K $90.00K $2.300M $400.0K $2.100M $0.00 $0.00 $100.0K $600.0K $200.0K $18.70M $16.50M $19.30M $12.90M $11.30M $8.300M $6.100M $70.10M $49.30M $19.30M $800.0K $700.0K $400.0K $600.0K $1.800M
Gross Profit $4.276M $5.483M $5.170M $1.300M $100.0K $24.80M $500.0K $0.00 $6.100M $1.500M $4.500M $9.000M $46.70M $19.20M $28.40M $27.50M $36.60M $26.90M $48.90M $15.10M $8.900M $4.900M $3.500M $2.500M $4.000M $300.0K
Gross Profit Margin 95.06% 97.22% 98.29% 35.14% 20.0% 92.19% 100.0% 98.39% 71.43% 95.74% 32.49% 73.89% 49.87% 68.77% 70.88% 81.7% 81.52% 41.13% 23.41% 31.45% 85.96% 85.37% 86.21% 86.96% 15.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $8.724M $8.225M $7.267M $5.900M $7.800M $12.00M $13.30M $13.90M $18.20M $13.40M $12.30M $10.60M $12.00M $12.60M $16.00M $17.30M $20.40M $16.50M $14.40M $10.10M $20.80M $11.30M $8.400M $5.700M $1.400M $1.200M $1.500M
YoY Change 6.07% 13.18% 23.17% -24.36% -35.0% -9.77% -4.32% -23.63% 35.82% 8.94% 16.04% -11.67% -4.76% -21.25% -7.51% -15.2% 23.64% 14.58% 42.57% -51.44% 84.07% 34.52% 47.37% 307.14% 16.67% -20.0%
% of Gross Profit 204.02% 150.01% 140.56% 453.85% 7800.0% 48.39% 3640.0% 201.64% 706.67% 266.67% 140.0% 34.26% 90.1% 71.83% 60.0% 39.34% 37.55% 42.54% 74.83% 94.38% 116.33% 40.0% 48.0% 37.5%
Research & Development $13.56M $12.51M $6.558M $1.500M $1.800M $2.900M $10.60M $16.40M $17.20M $21.50M $21.30M $20.00M $24.20M $21.30M $43.80M $57.10M $37.20M $25.90M $25.20M $17.40M $31.50M $15.40M $10.80M $6.700M $4.900M $5.200M $3.600M $2.100M
YoY Change 8.43% 90.7% 337.2% -16.67% -37.93% -72.64% -35.37% -4.65% -20.0% 0.94% 6.5% -17.36% 13.62% -51.37% -23.29% 53.49% 43.63% 2.78% 44.83% -44.76% 104.55% 42.59% 61.19% 36.73% -5.77% 44.44% 71.43%
% of Gross Profit 317.12% 228.09% 126.85% 115.38% 1800.0% 11.69% 3440.0% 349.18% 1333.33% 537.78% 236.67% 93.79% 297.4% 130.99% 94.18% 68.85% 64.68% 64.42% 101.99% 121.35% 136.73% 140.0% 208.0% 90.0% 700.0%
Depreciation & Amortization $169.0K $135.0K $145.0K $230.0K $320.0K $60.00K $90.00K $280.0K $340.0K $880.0K $950.0K $1.230M $1.690M $1.570M $10.84M $7.150M $5.570M $8.960M $5.940M $4.720M $6.730M $1.540M $1.190M $980.0K $690.0K $330.0K $180.0K $150.0K
YoY Change 25.19% -6.9% -36.96% -28.13% 433.33% -33.33% -67.86% -17.65% -61.36% -7.37% -22.76% -27.22% 7.64% -85.52% 51.61% 28.37% -37.83% 50.84% 25.85% -29.87% 337.01% 29.41% 21.43% 42.03% 109.09% 83.33% 20.0%
% of Gross Profit 3.95% 2.46% 2.8% 17.69% 320.0% 0.24% 68.0% 15.57% 82.0% 37.56% 17.44% 23.21% 37.24% 19.61% 32.58% 16.23% 17.55% 13.76% 10.2% 13.37% 20.0% 19.71% 13.2% 4.5% 50.0%
Operating Expenses $22.28M $12.51M $13.84M $7.500M $9.700M $14.90M $24.00M $30.40M $35.40M $34.90M $33.60M $31.20M $36.20M $33.80M $70.70M $81.60M $63.20M $51.30M $45.50M $32.20M $59.00M $28.30M $20.40M $13.40M $7.000M $6.700M $5.200M $2.200M
YoY Change 78.19% -9.65% 84.55% -22.68% -34.9% -37.92% -21.05% -14.12% 1.43% 3.87% 7.69% -13.81% 7.1% -52.19% -13.36% 29.11% 23.2% 12.75% 41.3% -45.42% 108.48% 38.73% 52.24% 91.43% 4.48% 28.85% 136.36%
Operating Profit -$18.01M -$7.023M -$8.671M -$6.200M -$9.600M $9.900M -$34.90M -$34.90M -$27.50M -$29.70M -$31.70M -$24.80M -$24.00M -$62.40M -$34.80M -$23.80M -$8.900M -$5.300M -$10.10M -$13.20M -$11.50M -$8.500M -$3.500M -$4.200M -$1.200M -$1.900M
YoY Change 156.41% -19.01% 39.85% -35.42% -196.97% 0.0% 26.91% -7.41% -6.31% 27.82% 3.33% -61.54% 79.31% 46.22% 167.42% 67.92% -47.52% -23.48% 14.78% 35.29% 142.86% -16.67% 250.0% -36.84%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense $907.0K $875.0K $208.0K $1.700M $4.600M $900.0K $2.700M $4.500M -$15.30M $20.30M $200.0K $6.600M $6.200M -$3.600M -$800.0K $3.800M $800.0K $300.0K -$5.900M -$2.600M -$3.000M $1.500M $1.900M $2.000M $900.0K $1.500M $1.300M $2.100M
YoY Change 3.66% 320.67% -87.76% -63.04% 411.11% -66.67% -40.0% -129.41% -175.37% 10050.0% -96.97% 6.45% -272.22% 350.0% -121.05% 375.0% 166.67% -105.08% 126.92% -13.33% -300.0% -21.05% -5.0% 122.22% -40.0% 15.38% -38.1%
% of Operating Profit 9.09%
Other Income/Expense, Net $1.000K -$14.00K -$700.0K -$600.0K $300.0K $100.0K $0.00 -$5.400M
YoY Change -107.14% -98.0% 16.67% -300.0% 200.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income -$16.55M -$22.73M -$8.477M -$4.700M -$6.200M $9.600M -$20.30M -$25.00M -$50.20M -$17.10M -$27.20M -$23.10M -$25.50M -$28.50M -$24.70M -$58.60M -$34.80M -$23.00M -$14.90M -$7.900M -$13.30M -$11.60M -$9.600M -$6.500M -$2.700M -$2.700M $100.0K $100.0K
YoY Change -27.17% 168.1% 80.36% -24.19% -164.58% -147.29% -18.8% -50.2% 193.57% -37.13% 17.75% -9.41% -10.53% 15.38% -57.85% 68.39% 51.3% 54.36% 88.61% -40.6% 14.66% 20.83% 47.69% 140.74% 0.0% -2800.0% 0.0%
Income Tax $0.00 $0.00 -$109.0K $400.0K -$200.0K $5.500M -$3.500M $0.00 $0.00 $100.0K $0.00 $0.00 $1.100M $0.00 $0.00 $1.200M -$2.000M -$29.00M $600.0K $200.0K $4.200M $2.800M -$3.100M $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 57.29% 0.0% 0.0%
Net Earnings -$16.55M -$22.73M -$8.368M -$5.100M -$6.000M $4.200M -$16.80M -$25.00M -$50.10M -$16.60M $6.800M -$20.40M -$27.10M -$28.50M -$24.70M -$59.80M -$33.10M $33.40M $10.60M -$3.400M -$20.10M -$16.40M -$2.200M -$6.500M -$2.700M -$2.700M $100.0K $100.0K
YoY Change -27.17% 171.59% 64.08% -15.0% -242.86% -125.0% -32.8% -50.1% 201.81% -344.12% -133.33% -24.72% -4.91% 15.38% -58.7% 80.66% -199.1% 215.09% -411.76% -83.08% 22.56% 645.45% -66.15% 140.74% 0.0% -2800.0% 0.0%
Net Earnings / Revenue -367.99% -402.96% -159.09% -137.84% -1200.0% 15.61% -1866.67% -2777.78% -10020.0% 109.68% -971.43% -576.6% -102.89% -39.08% -155.32% -80.15% 86.08% 23.66% -10.3% -16.9% -25.43% -7.77% -114.04% -65.85% -93.1% 2.17% 5.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.41 -$4.68 -$72.81K -$124.1K -$342.9K $247.1K -$1.120M -$2.427M -$17.89M -$27.67M $22.67M -$102.0M -$135.5M -$285.0M -$247.0M -$598.0M -$331.0M $334.0M $106.0M -$34.00M -$201.0M -$164.0M -$22.00M -$132.3M -$61.94M -$63.07M $1.310M $1.320M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $34.02M $50.61M $65.30M $24.30M $7.800M $14.50M $7.800M $22.00M $41.50M $34.90M $43.20M $39.50M $46.90M $33.90M $38.10M $49.70M $41.40M $60.50M $34.90M $48.30M $49.60M $51.90M $34.00M $45.80M $26.80M $20.80M $28.00M $24.40M
YoY Change -32.79% -22.49% 168.72% 211.54% -46.21% 85.9% -64.55% -46.99% 18.91% -19.21% 9.37% -15.78% 38.35% -11.02% -23.34% 20.05% -31.57% 73.35% -27.74% -2.62% -4.43% 52.65% -25.76% 70.9% 28.85% -25.71% 14.75%
Cash & Equivalents $0.00 $9.700M $24.30M $7.800M $14.50M $7.800M $0.00 $41.50M $24.10M $15.30M $24.10M $31.80M $19.10M $38.10M $49.20M $10.30M $8.900M $12.40M $23.70M $17.30M $7.900M $7.500M $4.800M $4.200M
Short-Term Investments $0.00 $24.10M $15.30M $24.10M $31.80M $21.00M $0.00 $500.0K $31.10M $51.60M $22.50M $24.60M $32.40M $43.90M $26.40M $41.00M $22.60M $20.60M $27.80M $24.00M
Other Short-Term Assets $1.942M $2.488M $1.772M $1.900M $1.200M $1.200M $700.0K $400.0K $300.0K $400.0K $500.0K $1.700M $1.500M $1.100M $2.900M $4.000M $3.600M $25.70M $111.4M $5.800M $4.600M $2.400M $700.0K $400.0K $200.0K $100.0K $0.00 $200.0K
YoY Change -21.95% 40.41% -6.74% 58.33% 0.0% 71.43% 75.0% 33.33% -25.0% -20.0% -70.59% 13.33% 36.36% -62.07% -27.5% 11.11% -85.99% -76.93% 1820.69% 26.09% 91.67% 242.86% 75.0% 100.0% 100.0% -100.0%
Inventory $66.00K $229.0K $73.00K $0.00 $1.200M $200.0K $600.0K $0.00 $4.100M $3.500M $3.300M $4.400M $3.400M $5.400M $5.000M $5.500M $17.80M $12.50M $10.40M $5.200M $1.700M $800.0K $900.0K $800.0K $400.0K
Prepaid Expenses
Receivables $67.00K $403.0K $877.0K $1.200M $200.0K $100.0K $0.00 $200.0K $600.0K $600.0K $1.700M $7.300M $7.700M $4.600M $2.400M $3.400M $6.200M $6.800M $9.600M $43.20M $32.80M $19.70M $12.30M $900.0K $2.400M $2.100M $2.800M $800.0K
Other Receivables $276.0K $1.757M $2.798M $500.0K $500.0K $200.0K $200.0K $200.0K $0.00 $300.0K $300.0K $700.0K $600.0K $800.0K $1.100M $1.200M $3.000M $3.700M $2.300M $5.300M $4.400M $27.90M $3.300M $3.100M $500.0K $800.0K $900.0K $900.0K
Total Short-Term Assets $36.37M $55.49M $70.82M $27.90M $10.90M $16.30M $9.400M $22.70M $42.40M $36.20M $45.70M $53.30M $60.10M $43.80M $49.00M $61.70M $59.60M $101.7M $163.7M $120.3M $103.8M $112.2M $55.50M $51.80M $30.70M $24.60M $32.60M $26.60M
YoY Change -34.46% -21.65% 153.84% 155.96% -33.13% 73.4% -58.59% -46.46% 17.13% -20.79% -14.26% -11.31% 37.21% -10.61% -20.58% 3.52% -41.4% -37.87% 36.08% 15.9% -7.49% 102.16% 7.14% 68.73% 24.8% -24.54% 22.56%
Property, Plant & Equipment $317.0K $216.0K $192.0K $200.0K $600.0K $100.0K $100.0K $200.0K $300.0K $800.0K $1.400M $2.100M $2.500M $3.100M $4.400M $6.700M $7.500M $13.00M $14.10M $16.50M $15.10M $13.80M $9.700M $10.00M $10.60M $6.000M $1.200M $500.0K
YoY Change 46.76% 12.5% -4.0% -66.67% 500.0% 0.0% -50.0% -33.33% -62.5% -42.86% -33.33% -16.0% -19.35% -29.55% -34.33% -10.67% -42.31% -7.8% -14.55% 9.27% 9.42% 42.27% -3.0% -5.66% 76.67% 400.0% 140.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $57.10M $0.00
YoY Change -100.0%
Other Assets $332.0K $322.0K $335.0K $300.0K $400.0K $400.0K $4.000M $1.100M $800.0K $1.400M $1.600M $1.600M $1.600M $1.600M $5.600M $6.000M $15.40M $4.800M $190.9M $19.10M $11.40M $11.60M $4.000M $400.0K $800.0K $700.0K $400.0K $200.0K
YoY Change 3.11% -3.88% 11.67% -25.0% 0.0% -90.0% 263.64% 37.5% -42.86% -12.5% 0.0% 0.0% 0.0% -71.43% -6.67% -61.04% 220.83% -97.49% 899.48% 67.54% -1.72% 190.0% 900.0% -50.0% 14.29% 75.0% 100.0%
Total Long-Term Assets $649.0K $538.0K $9.282M $9.400M $9.100M $8.700M $12.80M $9.000M $9.100M $11.20M $13.50M $14.40M $15.30M $17.60M $37.30M $46.60M $63.80M $121.8M $256.1M $170.0M $124.3M $98.30M $28.90M $15.30M $11.40M $6.800M $1.600M $700.0K
YoY Change 20.63% -94.2% -1.26% 3.3% 4.6% -32.03% 42.22% -1.1% -18.75% -17.04% -6.25% -5.88% -13.07% -52.82% -19.96% -26.96% -47.62% -52.44% 50.65% 36.77% 26.45% 240.14% 88.89% 34.21% 67.65% 325.0% 128.57%
Total Assets $37.02M $56.03M $80.10M $37.30M $20.00M $25.00M $22.20M $31.70M $51.50M $47.40M $59.20M $67.70M $75.40M $61.40M $86.30M $108.3M $123.4M $223.5M $419.8M $290.3M $228.1M $210.5M $84.40M $67.10M $42.10M $31.40M $34.20M $27.30M
YoY Change
Accounts Payable $1.866M $2.038M $934.0K $1.200M $1.100M $1.300M $1.200M $2.000M $4.200M $3.200M $4.800M $6.700M $8.100M $6.400M $8.200M $10.30M $11.40M $7.000M $4.000M $24.00M $25.60M $17.20M $11.20M $1.300M $1.700M $2.300M $1.100M $800.0K
YoY Change -8.44% 118.2% -22.17% 9.09% -15.38% 8.33% -40.0% -52.38% 31.25% -33.33% -28.36% -17.28% 26.56% -21.95% -20.39% -9.65% 62.86% 75.0% -83.33% -6.25% 48.84% 53.57% 761.54% -23.53% -26.09% 109.09% 37.5%
Accrued Expenses $1.756M $1.790M $1.738M $1.000M $900.0K $900.0K $1.600M $1.400M $2.300M $2.000M $3.800M $4.200M $2.900M $3.800M $3.400M $4.700M $2.800M $2.900M $9.300M $10.30M $6.100M $3.500M $2.600M
YoY Change -1.9% 2.99% 73.8% 11.11% 0.0% -43.75% 14.29% 15.0% -47.37% -9.52% 44.83% -23.68% 11.76% -27.66% 67.86% -3.45% -68.82% -9.71% 68.85% 74.29% 34.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $27.40M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $160.0K $114.0K $130.0K $100.0K $600.0K $0.00 $100.0K $100.0K $100.0K $0.00 $800.0K $700.0K $700.0K $10.10M $2.900M $2.000M $2.200M $200.0K
YoY Change 40.35% -12.31% 30.0% -83.33% -100.0% 0.0% 0.0% -100.0% 14.29% 0.0% -93.07% 248.28% 45.0% -9.09% 1000.0%
Total Short-Term Liabilities $4.540M $7.044M $7.766M $5.000M $5.700M $5.600M $5.800M $4.200M $6.400M $7.600M $7.200M $15.70M $17.90M $14.40M $19.30M $22.20M $22.30M $16.30M $64.20M $60.10M $47.40M $84.10M $16.90M $4.600M $1.700M $2.300M $1.100M $800.0K
YoY Change -35.55% -9.3% 55.32% -12.28% 1.79% -3.45% 38.1% -34.38% -15.79% 5.56% -54.14% -12.29% 24.31% -25.39% -13.06% -0.45% 36.81% -74.61% 6.82% 26.79% -43.64% 397.63% 267.39% 170.59% -26.09% 109.09% 37.5%
Long-Term Debt $119.0K $65.00K $31.00K $0.00 $300.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $200.0K $0.00 $700.0K $29.90M $53.40M $27.00M $6.300M $6.500M $3.200M $2.700M $300.0K $0.00 $0.00
YoY Change 83.08% 109.68% -100.0% -100.0% 0.0% -50.0% -100.0% -97.66% -44.01% 97.78% 328.57% -3.08% 103.13% 18.52% 800.0%
Other Long-Term Liabilities $14.16M $13.14M $19.32M $19.00M $16.50M $17.50M $19.20M $21.20M $23.50M $25.40M $34.90M $58.70M $62.00M $64.60M $57.60M $64.50M $12.50M $17.30M $207.6M $27.50M $13.30M $11.80M $100.0K $16.40M
YoY Change 7.76% -31.98% 1.68% 15.15% -5.71% -8.85% -9.43% -9.79% -7.48% -27.22% -40.55% -5.32% -4.02% 12.15% -10.7% 416.0% -27.75% -91.67% 654.91% 106.77% 12.71% 11700.0% -99.39%
Total Long-Term Liabilities $14.28M $13.21M $19.35M $19.00M $16.80M $17.50M $19.20M $21.20M $23.50M $25.40M $34.90M $58.70M $62.00M $64.70M $57.70M $64.70M $12.50M $18.00M $237.5M $80.90M $40.30M $18.10M $6.600M $19.60M $2.700M $300.0K $0.00 $0.00
YoY Change 8.13% -31.75% 1.84% 13.1% -4.0% -8.85% -9.43% -9.79% -7.48% -27.22% -40.55% -5.32% -4.17% 12.13% -10.82% 417.6% -30.56% -92.42% 193.57% 100.74% 122.65% 174.24% -66.33% 625.93% 800.0%
Total Liabilities $18.82M $20.25M $27.12M $24.10M $22.40M $23.10M $25.00M $25.40M $29.90M $33.00M $42.10M $74.40M $79.90M $79.00M $77.00M $86.90M $34.80M $44.60M $310.3M $190.3M $130.8M $140.3M $35.00M $24.20M $4.400M $2.500M $1.100M $800.0K
YoY Change -7.06% -25.32% 12.51% 7.59% -3.03% -7.6% -1.57% -15.05% -9.39% -21.62% -43.41% -6.88% 1.14% 2.6% -11.39% 149.71% -21.97% -85.63% 63.06% 45.49% -6.77% 300.86% 44.63% 450.0% 76.0% 127.27% 37.5%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $23.483 Million

About COSCIENS Biopharma Inc.

Aeterna Zentaris Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The firm is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The firm's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources, which are used in cosmeceutical products, such as oat beta glucan and avenanthramides, and is being developed as potential nutraceuticals and/or pharmaceuticals. Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-1.

Industry: Pharmaceutical Preparations Peers: Edesa Biotech, Inc. NYMOX PHARMACEUTICAL CORP Xenon Pharmaceuticals Inc.